UPDATE : Monday, June 17, 2019
상단여백
Daewoong to develop hearing loss treatment using ion-channel platform tech
Daewoong Pharmaceutical said that it has signed a contract with Yonsei Univ...
by Lee Han-soo  |  2019-06-14 17:27
라인
294 shareholders file suit against Kolon TissueGene for damage compensation
Kolon TissueGene said in a public filing on Thursday that its 294 minority ...
by Jeong Sae-im  |  2019-06-14 10:51
라인
AMC to develop AI-based monitoring system predicting immunotherapies’ side effects
A research team at Asan Medical Center has started a project to build big d...
by Lee Han-soo  |  2019-06-13 17:35
라인
Celltrion unveils P3 trial results for rheumatoid biosimilar in Europe
Celltrion has presented the phase 3 clinical trial result for Remsima SC, t...
by Lee Han-soo  |  2019-06-13 16:10
라인
GC MS to export cholesterol-gauging device to China
GC MS, a company specializing in diagnostic reagents and medical devices, w...
by Lee Han-soo  |  2019-06-13 16:09
라인
Physicians, industrialists split over WHO’s grouping of game into disease
The World Health Organization’s decision to put gaming disorder on the list...
by Song Soo-youn  |  2019-06-13 16:02
라인
LSK Global PS wins international recognition in clinical data management
LSK Global PS said it has obtained an international certification for clini...
by Lee Hye-seon  |  2019-06-13 14:30
라인
Handok to market Medtronic's continuous glucose monitoring device
Handok has signed an agreement with Medtronic Korea to market and distribut...
by Lee Han-soo  |  2019-06-13 11:53
라인
‘Many drugs won Chinese approval without review suspension’
Korean botulinum toxin maker Medytox is likely to face a delay in winning C...
by Jeong Sae-im  |  2019-06-13 11:26
라인
Researchers develop device administering drugs with infrared rays
A research team consisting of researchers from Seoul National University (S...
by Lee Han-soo  |  2019-06-12 16:54
라인
Daewoong’s botulinum toxin hits a snag in European approval
Daewoong Pharmaceutical is expected to face a delay in obtaining European a...
by Jeong Sae-im  |  2019-06-12 16:50
라인
Vaginal microbiome in pregnant women can predict premature birth
Vaginal microbiome in pregnant women could be used as an indicator to predi...
by Song Soo-youn  |  2019-06-12 14:43
라인
Novo Nordisk’s Saxenda dominates local obesity market
Novo Nordisk's Saxenda (ingredient: liraglutide), the world's first...
by Lee Han-soo  |  2019-06-12 14:16
라인
Atopic dermatitis patients demand reimbursement for Sanofi’s biological drug
Korean patients with severe atopic dermatitis gathered in front of the Nati...
by Kim Yun-mi  |  2019-06-12 13:29
라인
[Startups to Watch] 'Noul aims to become major player in eradicating malaria'
Malaria, a mosquito-borne disease, is one of the most common infectious dis...
by Lee Han-soo  |  2019-06-12 11:01
라인
US expert says Asians less vulnerable to dementia than Europeans
Alternative treatments can help dementia patients psychologically, if not p...
by Lee Han-soo  |  2019-06-11 17:53
라인
Forxiga prevents kidney disease in diabetes patients
AstraZeneca’s sodium-glucose cotransporter-2 (SGLT2) inhibitor Forxiga (ing...
by Kim Yun-mi  |  2019-06-11 15:40
라인
3 of 10 cancer survivors feel discriminated at work: survey
Three out of 10 Korean cancer survivors experienced workplace discriminatio...
by Kwak Sung-sun  |  2019-06-11 14:26
라인
‘Medytox got review suspension in China only once’
Korean botulinum toxin maker Medytox said the Chinese regulator ordered the...
by Jeong Sae-im  |  2019-06-11 10:50
라인
[ASCO 2019] Imfinzi 1st IO to report 3-year OS in unresectable stage III NSCLC
Chicago, Ill -- AstraZeneca‘s Imfinzi (Ingredient: durvalumab) has demonstr...
by Lee Han-soo, KBR Correspondent  |  2019-06-11 08:00
여백
여백
여백
Back to Top